Trulicity leads mixed third quarter for Lilly; shares sink
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St slips on rising bond yields; Walmart results weigh
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Eli Lilly (LLY) PT Lowered to $124 at BMO Capital
November 7, 2018 12:40 PM ESTBMO Capital analyst Alex Arfaei lowered the price target on Eli Lilly (NYSE: LLY) to $124.00 (from $130.00) while maintaining an Outperform rating.
The analyst comments, "Lilly had a mixed, incrementally negative 3Q18, but our thesis is unchanged. Although price pressure in the... More
